Zivo Bioscience Valuation
| ZIVODelisted Stock | USD 1.81 0.01 0.55% |
Based on Macroaxis valuation methodology, the company appears to be overvalued. Zivo Bioscience maintains a prevalent Real Value of $1.72 per share. The last-minute price of the company is $1.81. Our model calculates the value of Zivo Bioscience from examining the company fundamentals such as Shares Outstanding of 1.82 M, return on asset of -1.65, and Operating Margin of (133.25) % as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Zivo Bioscience's price fluctuation is very steady at this time. Calculation of the real value of Zivo Bioscience is based on 3 months time horizon. Increasing Zivo Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zivo Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zivo Stock. However, Zivo Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.81 | Real 1.72 | Hype 1.81 | Naive 1.64 |
The intrinsic value of Zivo Bioscience's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Zivo Bioscience's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Zivo Bioscience helps investors to forecast how Zivo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zivo Bioscience more accurately as focusing exclusively on Zivo Bioscience's fundamentals will not take into account other important factors: Zivo Bioscience Total Value Analysis
Zivo Bioscience is at this time anticipated to have valuation of 2.02 M with market capitalization of 2 M, debt of 445.18 K, and cash on hands of 5.08 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Zivo Bioscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.02 M | 2 M | 445.18 K | 5.08 M |
Zivo Bioscience Asset Utilization
One of the ways to look at asset utilization of Zivo is to check how much profit was generated for every dollar of assets it reports. Zivo Bioscience maintains a negative usage of resources of -1.65 (%), losing $0.0165 for each dollar of resources held by the company. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it maintains. Specifically, asset utilization of Zivo Bioscience shows how discouraging it operates for each dollar spent on its resources.Zivo Bioscience Ownership Allocation
Zivo Bioscience owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Zivo Bioscience Profitability Analysis
Net Loss for the year was (8.75 M) with profit before overhead, payroll, taxes, and interest of 20 K.About Zivo Bioscience Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Zivo Bioscience. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Zivo Bioscience based exclusively on its fundamental and basic technical indicators. By analyzing Zivo Bioscience's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Zivo Bioscience's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zivo Bioscience. We calculate exposure to Zivo Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zivo Bioscience's related companies.ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.
Zivo Bioscience Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.6 M |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |